Bgm (BGM) Construction in Progress (2019 - 2025)
Bgm's (BGM) quarterly Construction in Progress came in at $4.0 million in Q3 2025, down 28.52% year-on-year from $5.6 million in Q3 2024, and up 4.0% on a QoQ basis from $3.9 million in Q1 2025.
Bgm (BGM) Construction in Progress (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Construction in Progress data on file, last reported at $4.0 million in Q3 2025.
- On a quarterly basis, Construction in Progress fell 28.52% year-over-year to $4.0 million in Q3 2025; TTM through Sep 2025 was $4.0 million, a 28.52% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 28.52% from the prior year.
- Construction in Progress for Q3 2025 stood at $4.0 million, up from $3.9 million in the prior quarter.
- Over the last five years, Construction in Progress for BGM reached as high as $5.6 million in Q3 2024 and fell as low as $1.2 million in Q3 2022.
- Historically, Construction in Progress has averaged $3.3 million across 5 years, with a median of $3.6 million in 2024.
- Across the five-year window, Construction in Progress surged 1170.93% in 2021 and plunged 40.67% in 2022, its largest moves.
- Year by year, Construction in Progress stood at $2.0 million in 2021, then plunged by 40.67% to $1.2 million in 2022, then surged by 139.22% to $2.9 million in 2023, then surged by 96.68% to $5.6 million in 2024, then retreated by 28.52% to $4.0 million in 2025.
- Per Business Quant data, the three most recent Construction in Progress figures were $4.0 million in Q3 2025, $3.9 million in Q1 2025, and $5.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.03 Mn |
| Mar 31, 2025 | 3.88 Mn |
| Sep 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 3.65 Mn |
| Sep 30, 2023 | 2.87 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Sep 30, 2021 | 2.02 Mn |
| Sep 30, 2020 | 158,975.00 |
| Sep 30, 2019 | 148,197.00 |